Social media addiction and the hyperconsumptive lifestyles of the 21st century often mean tourists forget the real purpose of their visit.

・The deal values Amicus at $14.50 per share, representing a 33% premium to its $10.90 closing price on Thursday. ・Amicus settled its patent dispute with Indian drugmakers Aurobindo Pharma and Lupin ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. Join us Jan. 14 for a virtual discussion about our Rx ...

SALT LAKE CITY — The Utah Department of Commerce's Division of Consumer Protection and the Utah Attorney General's Office have reached a settlement with global pharmaceutical company Sandoz Inc. in a ...

The exchange-traded fund market is bursting at its seams after adding over 1,000 ETFs so far in 2025, but few have earned a role in investor portfolios. The proverbial spaghetti cannon has fired a ...